Keystone XL--formally the Keystone Gulf Coast Expansion Project--was rejected this week. But it’s on track to come on line in late 2014. Read More

The boom in onshore oil and gas drilling continues to redound throughout the US economy. Read More

2012 is shaping up to be an "annus horribilis" for the drug industry thanks to a large number of patent expirations. Some drug stocks will thrive regardless and Jim names a few. Read More

Natural gas is priced at levels not seen since the 1990s. Abnormally warm weather in key regions suggests they’ll remain depressed. Here’s how natural gas prices impact dividend-paying energy stocks. Read More

The HSBC Financial Clog Index provides a quick, clean look at the level of stress in the system. Read More

Despite the uncertain global economic environment, mining stocks have several positive attributes. When choosing a miner, bigger is always better. Read More

Lennar's sales rose 11% in the fourth quarter of 2011, leading some analysts to ask if a housing rebound is under way. Read More

With the Detroit Auto Show in full swing, cars are on Jim's mind. Several automobile stocks look like attractive investments, but one looks better than all the rest. Read More

It could be difficult for investors to capitalize on the latest advance in gene sequencing. But we’ve found one ETF that provides broad exposure to this disruptive technology.   Read More

All things considered--and this, too, is a relative game--there’s little reason for investors to fear Australian politicians. Read More